GlassScriptPhysician profile
Ajay Desai
NPI 1124015706
$7,910.17
in general payments reported to CMS, 2019-2025
63 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,731 · 2020: $1,501 · 2021: $537 · 2022: $1,117 · 2023: $735 · 2024: $810 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,025.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $823.92 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Astrazeneca Pharmaceuticals LP | $465.09 | 2019-2025 | Tagrisso, Calquence |
| E.R. Squibb & Sons, L.L.C. | $449.86 | 2019-2025 | Opdivo |
| Pharmacyclics LLC, An Abbvie Company | $376.84 | 2019-2023 | Imbruvica, Epkinly |
| Amgen INC. | $351.07 | 2019-2023 | Lumakras |
| Genzyme Corporation | $342.24 | 2020-2024 | |
| Incyte Corporation | $334.15 | 2019-2024 | Monjuvi |
| Takeda Pharmaceuticals U.S.A., INC. | $302.60 | 2019-2024 | Fruzaqla |
| Tesaro, INC. | $256.86 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $228.43 | 2019-2023 | |
| Exelixis INC. | $217.51 | 2019-2025 | Cabometyx |
| Merck Sharp & Dohme LLC | $206.94 | 2019-2025 | Keytruda, Keytruda Qlex |
| Genentech USA, INC. | $201.41 | 2019-2024 | Tecentriq |
| Glaxosmithkline, LLC. | $188.85 | 2020-2023 | |
| Seagen INC. | $166.48 | 2019-2020 |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.